ISBT 128

ISBT 128 is a global standard for the identification, labeling, and information processing of human blood, tissue, and cell products across international borders and health care systems. It is used by more than 80 countries and is endorsed by the World Health Organization (WHO) and the International Society of Blood Transfusion (ISBT).

Overview

ISBT 128 is a system designed to ensure the highest levels of accuracy, safety, and efficiency for patients, donors, and healthcare professionals. It uses a unique numeric identifier for each product, which can be barcoded for easy scanning and tracking. This identifier includes information about the product's origin, type, and characteristics.

History

The ISBT 128 standard was developed by the International Council for Commonality in Blood Banking Automation (ICCBBA), a non-profit organization dedicated to improving safety and efficiency in the field of transfusion medicine. The standard was first published in 1994 and has been updated regularly since then to incorporate new technologies and practices.

Implementation

Implementing ISBT 128 requires a comprehensive approach that includes changes to labeling practices, information systems, and staff training. The ICCBBA provides detailed implementation guides and other resources to assist organizations in this process.

Benefits

The use of ISBT 128 can bring a number of benefits, including improved patient safety, increased efficiency, and enhanced traceability of blood, tissue, and cell products. It can also facilitate international exchange and compatibility of products.

See also

• Blood transfusion
• Tissue transplantation
• Cell therapy
• International Council for Commonality in Blood Banking Automation

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia